MEDICLIN AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.7 EUR | +1.50% |
|
0.00% | -1.46% |
| Mar. 27 | MEDICLIN Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 22 | Mediclin to Buy Rehabilitation Clinic in Germany | MT |
| Sales 2024 * | 730M 775M | Sales 2025 * | 752M 798M | Capitalization | 128M 136M |
|---|---|---|---|---|---|
| Net income 2024 * | 16M 16.98M | Net income 2025 * | 20M 21.22M | EV / Sales 2024 * | 0.18 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.17 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 10,073 |
| Yield 2024 * |
1.48% | Yield 2025 * |
1.48% | Free-Float | 12.27% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +1.50% | ||
| Current month | +6.30% | ||
| 1 month | +14.41% | ||
| 6 months | +1.50% | ||
| Current year | -1.46% |
1 week
2.60
2.70
1 month
2.302.70
Current year
2.282.76
1 year
2.283.10
3 years
2.284.60
5 years
2.285.70
10 years
2.286.88
| Managers | Title | Age | Since |
|---|---|---|---|
Joachim Ramming
CEO | Chief Executive Officer | - | 21-07-31 |
Tino Marco Fritz
DFI | Director of Finance/CFO | 47 | 18-08-31 |
Jörg Störmer
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michael Bock
BRD | Director/Board Member | 61 | 05-05-24 |
Marco Walker
BRD | Director/Board Member | 48 | 20-09-23 |
| Director/Board Member | 61 | 12-09-19 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 2.7 | +1.50% | 2,273 |
| 24-04-17 | 2.66 | 0.00% | 700 |
| 24-04-16 | 2.66 | 0.00% | 700 |
| 24-04-15 | 2.66 | 0.00% | 700 |
| 24-04-12 | 2.66 | -1.48% | 2,484 |
Delayed Quote Xetra, April 18, 2024 at 11:36 am EDT
More quotes
Mediclin AG is a Germany-based operators of healthcare facilities. The Company operates more than 50 facilities across Germany. Its portfolio comprises hospitals (acute care), rehabilitation clinics, care homes and medical care centers. The Group also offers a range of specialist medical services, such as neurosurgery, as well as specialist facilities, including heart centers, early neurological rehabilitation facilities and a specialist orthopedic hospital. In addition to that, it offers specialist services in the area of neuroradiology, as well as in psychological sciences (psychosomatics and psychiatry), orthopedics, in the areas of Ear, nose, and throat (ENT), oncology (radiotherapy) and inner medicine (including cardiology, pneumology and endocrinology).
Calendar
2024-05-01
- Q1 2024 Earnings Release
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.7
EUR
Average target price
5.1
EUR
Spread / Average Target
+88.89%
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -1.46% | 134M | |
| -21.49% | 16.12B | |
| +0.90% | 11.99B | |
| +1.00% | 11.19B | |
| +6.49% | 10.89B | |
| +17.84% | 7.98B | |
| -5.55% | 7.5B | |
| +22.00% | 7.37B | |
| +3.81% | 6.7B | |
| +43.14% | 4.45B |
- Stock Market
- Equities
- MED Stock
